• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对1295例乳腺癌新鲜样本的流式细胞术DNA直方图进行半自动细胞周期分析的实验室间可重复性。

Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.

作者信息

Bergers E, Montironi R, van Diest P J, Prete E, Baak J P

机构信息

Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.

出版信息

Hum Pathol. 1996 Jun;27(6):553-60. doi: 10.1016/s0046-8177(96)90161-6.

DOI:10.1016/s0046-8177(96)90161-6
PMID:8666364
Abstract

Conflicting prognostic results have been published as to the DNA variables, such as DNA ploidy, DNA index, and % S-phase cells for breast cancer patients. These variables can be obtained by interpreting DNA histograms by cell cycle analysis. Explanations for these conflicting results might be found on the level of the interpretation of the DNA histograms. In a previous study, the semi automated cell cycle analysis computer program MultiCycle (Phoenix Flow Systems, San Diego, CA) showed high intralaboratory reproducibility. However, what types of DNA histograms may cause disagreements was still unclear. The aim of this study was to determine the interlaboratory reproducibility of MultiCycle-based cell cycle analysis of 1,295 flow cytometric DNA histograms derived from fresh frozen breast cancer material and to clarify potential sources of interobserver variation when analyzing DNA histograms. DNA ploidy classification into diploid, hyperdiploid, tetraploid, hypertetraploid, and multiploid showed an interlaboratory agreement of 94% (kappa value = 0.92). The 6% discrepancies (n = 74) were caused by tetraploid peaks, as established in one laboratory, which shifted outside the tetraploid region on reanalysis by the other laboratory (37%), shoulders sometimes interpreted as peaks (24%), small peaks not always recognized as such (24%), fitting failures (10%), and overlooking of tetraploid peaks (5%). Furthermore, the cell cycle analysis variables showed variable reproducibility. The % S-phase cells of the first, second, and third cell cycle showed overall a moderate reproducibility (0.62 < or = R < or = 0.79), but the average % S-phase cells and the average aneuploid % S-phase cells were more reproducible with correlation coefficients of 0.89 and 0.81, respectively. The coefficient of variation of the G0/G1 peak of the first cell cycle, the DNA indices and the % diploid cells were highly reproducible (R > or = 0.94), and the % G2/M-phase cells of the first, second, and third cell cycle were poorly reproducible (0.22 < or = R < or = 0.68). When a cut-point was used at the mean value of 7% for the average % S-phase cells, the number of "threshold discrepancy cases" was 6%. Sources of variation for cell cycle analysis were variations in the debris correction procedures, disagreement about the modes of the aneuploid peaks, disagreement about small peaks, shoulders sometimes interpreted as peaks, and overlooking of tetraploid peaks.

摘要

关于乳腺癌患者的DNA变量,如DNA倍体、DNA指数和S期细胞百分比,已经发表了相互矛盾的预后结果。这些变量可以通过细胞周期分析解释DNA直方图来获得。对于这些相互矛盾的结果的解释可能可以在DNA直方图的解释层面找到。在之前的一项研究中,半自动细胞周期分析计算机程序MultiCycle(Phoenix Flow Systems,圣地亚哥,加利福尼亚州)显示出较高的实验室内重复性。然而,何种类型的DNA直方图可能导致分歧仍不清楚。本研究的目的是确定基于MultiCycle的对1295份来自新鲜冷冻乳腺癌材料的流式细胞术DNA直方图进行细胞周期分析的实验室间重复性,并在分析DNA直方图时阐明观察者间差异的潜在来源。DNA倍体分类为二倍体、超二倍体、四倍体、超四倍体和多倍体,显示实验室间一致性为94%(kappa值=0.92)。6%的差异(n = 74)是由四倍体峰引起的,如在一个实验室中确定的,在另一个实验室重新分析时,这些峰移出了四倍体区域(37%),有时将肩部解释为峰(24%),小峰并非总是被识别为小峰(24%),拟合失败(10%),以及忽略四倍体峰(5%)。此外,细胞周期分析变量显示出不同的重复性。第一、第二和第三个细胞周期的S期细胞百分比总体显示出中等重复性(0.62≤R≤0.79),但平均S期细胞百分比和平均非整倍体S期细胞百分比的重复性更高,相关系数分别为0.89和0.81。第一个细胞周期的G0/G1峰、DNA指数和二倍体细胞百分比的变异系数具有高度重复性(R≥),而第一、第二和第三个细胞周期的G2/M期细胞百分比的重复性较差(0.22≤R≤0.68)。当将平均S期细胞百分比的切点设定为7%的平均值时,“阈值差异病例”的数量为6%。细胞周期分析的变异来源包括碎片校正程序的差异、关于非整倍体峰模式的分歧、关于小峰的分歧、有时将肩部解释为峰以及忽略四倍体峰。

相似文献

1
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.对1295例乳腺癌新鲜样本的流式细胞术DNA直方图进行半自动细胞周期分析的实验室间可重复性。
Hum Pathol. 1996 Jun;27(6):553-60. doi: 10.1016/s0046-8177(96)90161-6.
2
Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material.新鲜乳腺癌组织流式细胞术DNA直方图半自动细胞周期分析的可重复性
Anal Cell Pathol. 1995 Jan;8(1):1-13.
3
Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer.应用于1414例新鲜冷冻乳腺癌流式细胞术DNA直方图的五种细胞周期分析模型的比较
Cytometry. 1997 Feb 15;30(1):54-60.
4
Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP).1301例乳腺癌患者流式细胞术DNA直方图不同细胞周期分析模型的预后意义:多中心形态计量乳腺癌项目(MMMCP)的结果
Int J Cancer. 1997 Jun 20;74(3):260-9. doi: 10.1002/(sici)1097-0215(19970620)74:3<260::aid-ijc5>3.0.co;2-x.
5
Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.通过流式细胞术测量的乳腺癌中DNA细胞周期变量的肿瘤异质性。
J Clin Pathol. 1996 Nov;49(11):931-7. doi: 10.1136/jcp.49.11.931.
6
Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.对932份新鲜冷冻乳腺癌材料的流式细胞术DNA直方图进行细胞周期分析。流式细胞术、临床和病理变量之间的相关性。MMMCP协作组。多中心形态计量学乳腺癌项目协作组。
Cancer. 1996 Jun 1;77(11):2258-66. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2258::AID-CNCR12>3.0.CO;2-W.
7
A rule-based expert system for the automatic classification of DNA "ploidy" histograms measured by the CAS 200 image analysis system.一种基于规则的专家系统,用于对由CAS 200图像分析系统测量的DNA“倍性”直方图进行自动分类。
Cytometry. 1997 Feb 15;30(1):39-46. doi: 10.1002/(sici)1097-0320(19970215)30:1<39::aid-cyto6>3.0.co;2-a.
8
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.乳腺癌DNA流式细胞术分析的可重复性:12个实验室对67份样本匀浆检测结果的比较
Cytometry. 1995 Jun 15;22(2):115-27. doi: 10.1002/cyto.990220207.
9
Reproducibility of DNA ploidy and S-phase values from paraffin-embedded tissue.石蜡包埋组织中DNA倍体和S期值的可重复性
Anal Quant Cytol Histol. 1996 Aug;18(4):316-22.
10
Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.流式细胞术DNA直方图的自动峰值检测和细胞周期分析。
Cytometry. 1994 Jul 1;16(3):250-5. doi: 10.1002/cyto.990160309.

引用本文的文献

1
Assessment of Chromosomal Aberrations and S-phase Fraction in Patients With Esophageal Cancer.食管癌患者染色体畸变与S期细胞分数的评估
Cureus. 2025 May 15;17(5):e84204. doi: 10.7759/cureus.84204. eCollection 2025 May.
2
Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of Lisbon.重新审视DNA流式细胞术在乳腺癌中的预后相关性:里斯本葡萄牙肿瘤研究所的25年经验
Oncol Lett. 2017 Apr;13(4):2027-2033. doi: 10.3892/ol.2017.5718. Epub 2017 Feb 13.
3
Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma.
在巴雷特腺癌切片上通过标准流式细胞术和图像细胞术对DNA直方图进行比较。
BMC Clin Pathol. 2008 May 30;8:5. doi: 10.1186/1472-6890-8-5.
4
Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.通过比较基因组杂交(CGH)和免疫组织化学揭示具有癌变过程中假定分级进展的一组乳腺癌的解读。
Br J Cancer. 2004 Apr 5;90(7):1422-8. doi: 10.1038/sj.bjc.6601658.
5
Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.乳腺癌中S期细胞分数与Ki-67指数的预后比较研究
J Clin Pathol. 2001 Jul;54(7):543-9. doi: 10.1136/jcp.54.7.543.
6
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.巴雷特食管进展为癌症的预测因素:基线组织学和流式细胞术可识别低风险和高风险患者亚组。
Am J Gastroenterol. 2000 Jul;95(7):1669-76. doi: 10.1111/j.1572-0241.2000.02196.x.
7
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.乳腺癌中DNA倍体和细胞增殖的短期意义:对308例患者预后标志物的多变量分析
J Clin Pathol. 1999 Aug;52(8):604-11. doi: 10.1136/jcp.52.8.604.
8
Proliferation markers in tumours: interpretation and clinical value.肿瘤中的增殖标志物:解读与临床价值。
J Clin Pathol. 1998 Oct;51(10):716-24. doi: 10.1136/jcp.51.10.716.
9
Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.结直肠肝转移中增殖活性、DNA倍体、p53和Ki-ras点突变的预后意义
Cell Prolif. 1998 Jun-Aug;31(3-4):139-53. doi: 10.1046/j.1365-2184.1998.00116.x.
10
Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.通过流式细胞术测量的乳腺癌中DNA细胞周期变量的肿瘤异质性。
J Clin Pathol. 1996 Nov;49(11):931-7. doi: 10.1136/jcp.49.11.931.